Charles A Hart insider trades: Bioheart (BHRT.OB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 6, 2012 | BHRT.OB | ↑ Buy | 3,571,430 | $0.01 | $50K | Direct | Feb 10, 2012 (4d) |
| Dec 13, 2010 | BHRT.OB | ↑ Buy | 675,580 | $0.15 | $101K | Direct | Dec 17, 2010 (4d) |
| Nov 30, 2010 | BHRT.OB | ↑ Buy | 180,620 | $0.15 | $27K | Direct | Dec 6, 2010 (6d) |
| Mar 16, 2010 | BHRT | ↑ Buy | 7,200 | $0.54 | $4K | By spouse | Apr 14, 2010 (29d) |
| Mar 4, 2010 | BHRT.OB | ↑ Buy | 103,770 | $0.53 | $55K | Direct | Mar 5, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Charles A Hart's insider trades
Charles A Hart is a director at Bioheart (BHRT.OB). Since Mar 4, 2010, Charles has reported 5 open-market purchases worth $237K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), other transactions (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BHRT.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.